GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

STXS · Jun 30, 2026

Stereotaxis, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001493152-26-037357General Corporate
Capex intensity50thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.83% · OPTIONAL · VALID

Operating cash generation19thOwn-history percentile · N=16
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-47.91% · OPTIONAL · VALID

Revenue growth25thOwn-history percentile · N=12
Evidence method

Yoy · gp.fundamentals.revenue

-12.82% · CORE · VALID

Inventory pressure88thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

163.23% · OPTIONAL · VALID

Gross margin63thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.gross_margin

58.49% · CORE · VALID

Operating margin94thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.operating_margin

-59.56% · CORE · VALID

R&D intensity19thOwn-history percentile · N=16
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

31.16% · OPTIONAL · VALID

SBC intensity0thOwn-history percentile · N=16
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

20.96% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History17 statesSelf-history eligible
Jun 30, 20220/7 normalizedLevel 3Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20246/7 normalizedLevel 3Sep 30, 20246/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20257/7 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
1.26%
Current
0.83%
Delta
-0.42%
Cash Generation Increased
Previous
-54.71%
Current
-47.91%
Delta
6.80%
Growth Increased
Previous
-15.81%
Current
-12.82%
Delta
2.98%
Inventory Pressure Decreased
Previous
166.83%
Current
163.23%
Delta
-3.59%
Margin Decreased
Previous
60.31%
Current
58.49%
Delta
-1.82%
Profitability Increased
Previous
-95.07%
Current
-59.56%
Delta
35.52%
R And D Intensity Decreased
Previous
38.10%
Current
31.16%
Delta
-6.94%
Sbc Intensity Decreased
Previous
33.54%
Current
20.96%
Delta
-12.58%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Sep 30, 2025
Similarity
65%
Compared
8 dimensions
Coverage
100%
Growth 13.9 · Margin 16.3 · Profitability 78.4 · Sbc Intensity 15.4 · Capex Intensity 50.0 · Cash Generation 11.1 · R And D Intensity 19.7 · Inventory Pressure 4.8
Mar 31, 2025
Similarity
65%
Compared
6 dimensions
Coverage
75%
Margin 26.1 · Profitability 48.3 · Sbc Intensity 18.2 · Cash Generation 63.1 · R And D Intensity 9.7 · Inventory Pressure 3.4
Sep 30, 2024
Similarity
62%
Compared
6 dimensions
Coverage
75%
Margin 62.5 · Profitability 38.2 · Sbc Intensity 0.0 · Cash Generation 7.6 · R And D Intensity 18.8 · Inventory Pressure 54.2
Mar 31, 2026
Similarity
62%
Compared
8 dimensions
Coverage
100%
Growth 6.8 · Margin 17.5 · Profitability 87.1 · Sbc Intensity 26.7 · Capex Intensity 4.5 · Cash Generation 5.4 · R And D Intensity 54.6 · Inventory Pressure 5.8
Research Graph

Related governed research

Analogous To · STXS state analogue 4 →Analogous To · STXS state analogue 2 →Analogous To · STXS state analogue 1 →Analogous To · STXS state analogue 3 →Compared To · Electromedical & Electrotherapeutic Apparatus peers →Transitioned To · STXS Fundamental State →Transitioned To · STXS CAPEX_INTENSITY_DECREASED →Transitioned To · STXS CASH_GENERATION_INCREASED →Transitioned To · STXS GROWTH_INCREASED →Transitioned To · STXS INVENTORY_PRESSURE_DECREASED →Transitioned To · STXS MARGIN_DECREASED →Transitioned To · STXS PROFITABILITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.